Literature DB >> 17189680

Cytokine regulation of MMP-9 in peripheral glia: implications for pathological processes and pain in injured nerve.

Sharmila Chattopadhyay1, Robert R Myers, Julie Janes, Veronica Shubayev.   

Abstract

Matrix metalloproteinase-9 (MMP-9) is an extracellular protease that is induced in Schwann cells hours after peripheral nerve injury and controls axonal degeneration and macrophage recruitment to the lesion. Here, we report a robust (90-fold) increase in MMP-9 mRNA within 24 h after rat sciatic nerve crush (1 to 60 days time-course). Using direct injection into a normal sciatic nerve, we identify the proinflammatory cytokines TNF-alpha and IL-1beta as potent regulators of MMP-9 expression (Taqman qPCR, zymography). Myelinating Schwann cells produced MMP-9 in response to cytokine injection and crush nerve injury. MMP-9 gene deletion reduced unstimulated neuropathic nociceptive behavior after one week post-crush and preserved myelin thickness by protecting myelin basic protein (MBP) from degradation, tested by Western blot and immunofluorescence. These data suggest that MMP-9 expression in peripheral nerve is controlled by key proinflammatory cytokine pathways, and that its removal protects nerve fibers from demyelination and reduces neuropathic pain after injury.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17189680      PMCID: PMC2865892          DOI: 10.1016/j.bbi.2006.10.015

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  60 in total

1.  The role of TNF-alpha during Wallerian degeneration.

Authors:  M Liefner; H Siebert; T Sachse; U Michel; G Kollias; W Brück
Journal:  J Neuroimmunol       Date:  2000-08-01       Impact factor: 3.478

2.  Upregulation and interaction of TNFalpha and gelatinases A and B in painful peripheral nerve injury.

Authors:  V I Shubayev; R R Myers
Journal:  Brain Res       Date:  2000-02-07       Impact factor: 3.252

Review 3.  The role of neuroinflammation in neuropathic pain: mechanisms and therapeutic targets.

Authors:  Robert R Myers; W Marie Campana; Veronica I Shubayev
Journal:  Drug Discov Today       Date:  2006-01       Impact factor: 7.851

4.  Differences in susceptibility of MBP charge isomers to digestion by stromelysin-1 (MMP-3) and release of an immunodominant epitope.

Authors:  Cheryl A D'Souza; Mario A Moscarello
Journal:  Neurochem Res       Date:  2006-07-27       Impact factor: 3.996

5.  TNFalpha-induced MMP-9 promotes macrophage recruitment into injured peripheral nerve.

Authors:  Veronica I Shubayev; Mila Angert; Jennifer Dolkas; W Marie Campana; Kai Palenscar; Robert R Myers
Journal:  Mol Cell Neurosci       Date:  2005-11-16       Impact factor: 4.314

6.  Interleukin-1 is a key regulator of matrix metalloproteinase-9 expression in human neurons in culture and following mouse brain trauma in vivo.

Authors:  G G Vecil; P H Larsen; S M Corley; L M Herx; A Besson; C G Goodyer; V W Yong
Journal:  J Neurosci Res       Date:  2000-07-15       Impact factor: 4.164

7.  MMP-2 and MMP-9 increase the neurite-promoting potential of schwann cell basal laminae and are upregulated in degenerated nerve.

Authors:  T A Ferguson; D Muir
Journal:  Mol Cell Neurosci       Date:  2000-08       Impact factor: 4.314

8.  Matrix metalloproteinase-2 facilitates wound healing events that promote functional recovery after spinal cord injury.

Authors:  Jung-Yu C Hsu; Robert McKeon; Staci Goussev; Zena Werb; Jung-Uek Lee; Alpa Trivedi; Linda J Noble-Haeusslein
Journal:  J Neurosci       Date:  2006-09-27       Impact factor: 6.167

9.  Myelin formation during development of the CNS is delayed in matrix metalloproteinase-9 and -12 null mice.

Authors:  Peter H Larsen; Angelika Goncalves DaSilva; Katherine Conant; V Wee Yong
Journal:  J Neurosci       Date:  2006-02-22       Impact factor: 6.167

10.  Sustained ERK phosphorylation is necessary but not sufficient for MMP-9 regulation in endothelial cells: involvement of Ras-dependent and -independent pathways.

Authors:  E Genersch; K Hayess; Y Neuenfeld; H Haller
Journal:  J Cell Sci       Date:  2000-12       Impact factor: 5.285

View more
  46 in total

1.  Upregulation of inflammatory mediators in a model of chronic pain after spinal cord injury.

Authors:  Rajat Sandhir; Eugene Gregory; Yong-Yue He; Nancy E J Berman
Journal:  Neurochem Res       Date:  2011-02-03       Impact factor: 3.996

2.  Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain.

Authors:  Yasuhiko Kawasaki; Zhen-Zhong Xu; Xiaoying Wang; Jong Yeon Park; Zhi-Ye Zhuang; Ping-Heng Tan; Yong-Jing Gao; Kristine Roy; Gabriel Corfas; Eng H Lo; Ru-Rong Ji
Journal:  Nat Med       Date:  2008-02-10       Impact factor: 53.440

Review 3.  "Listening" and "talking" to neurons: implications of immune activation for pain control and increasing the efficacy of opioids.

Authors:  Linda R Watkins; Mark R Hutchinson; Erin D Milligan; Steven F Maier
Journal:  Brain Res Rev       Date:  2007-07-13

4.  Matrix metalloproteinase inhibition enhances the rate of nerve regeneration in vivo by promoting dedifferentiation and mitosis of supporting schwann cells.

Authors:  Huaqing Liu; Youngsoon Kim; Sharmila Chattopadhyay; Igor Shubayev; Jennifer Dolkas; Veronica I Shubayev
Journal:  J Neuropathol Exp Neurol       Date:  2010-04       Impact factor: 3.685

Review 5.  The neuroimmunology of degeneration and regeneration in the peripheral nervous system.

Authors:  A DeFrancesco-Lisowitz; J A Lindborg; J P Niemi; R E Zigmond
Journal:  Neuroscience       Date:  2014-09-19       Impact factor: 3.590

6.  Physiologic facet capsule stretch can induce pain & upregulate matrix metalloproteinase-3 in the dorsal root ganglia when preceded by a physiological mechanical or nonpainful chemical exposure.

Authors:  Sagar Singh; Sonia Kartha; Ben A Bulka; Nicholas S Stiansen; Beth A Winkelstein
Journal:  Clin Biomech (Bristol, Avon)       Date:  2018-01-31       Impact factor: 2.063

7.  MMPs initiate Schwann cell-mediated MBP degradation and mechanical nociception after nerve damage.

Authors:  Hideo Kobayashi; Sharmila Chattopadhyay; Kinshi Kato; Jennifer Dolkas; Shin-Ichi Kikuchi; Robert R Myers; Veronica I Shubayev
Journal:  Mol Cell Neurosci       Date:  2008-09-05       Impact factor: 4.314

8.  Autotaxin and lysophosphatidic acid1 receptor-mediated demyelination of dorsal root fibers by sciatic nerve injury and intrathecal lysophosphatidylcholine.

Authors:  Jun Nagai; Hitoshi Uchida; Yosuke Matsushita; Ryo Yano; Mutsumi Ueda; Masami Niwa; Junken Aoki; Jerold Chun; Hiroshi Ueda
Journal:  Mol Pain       Date:  2010-11-09       Impact factor: 3.395

9.  Leptin derived from adipocytes in injured peripheral nerves facilitates development of neuropathic pain via macrophage stimulation.

Authors:  Takehiko Maeda; Norikazu Kiguchi; Yuka Kobayashi; Toshihiko Ikuta; Masanobu Ozaki; Shiroh Kishioka
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-20       Impact factor: 11.205

10.  A shed form of LDL receptor-related protein-1 regulates peripheral nerve injury and neuropathic pain in rodents.

Authors:  Alban Gaultier; Sanja Arandjelovic; Xiaoqing Li; Julie Janes; Nikola Dragojlovic; George P Zhou; Jenny Dolkas; Robert R Myers; Steven L Gonias; W Marie Campana
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.